| 1357 |
National Cancer Institute |
Html |
en |
Fatigue (PDQ®)–Health Professional Version |
Expert-reviewed information summary about fatigue, a condition marked by extreme tiredness and inability to function because of lack of energy, often seen as a complication of cancer or its treatment. |
| fatigue syndrome | 0.551792 |
| severe fatigue | 0.49185 |
| cancer-related fatigue | 0.710712 |
| Fatigue Coalition | 0.462842 |
| fatigue ratings | 0.435783 |
| fatigue | 0.998693 |
| exhibit peak fatigue | 0.502775 |
| fatigue severity | 0.46154 |
| Cancer Nurs | 0.388926 |
| fatigue outcomes. | 0.43447 |
| evening fatigue | 0.483354 |
| muscle fatigue | 0.440015 |
| chronic fatigue | 0.543247 |
| cancer treatment–related fatigue | 0.605063 |
| breast cancer patients | 0.407613 |
| patients | 0.57543 |
| cancer patients | 0.477381 |
| Fatigue Symptom Inventory | 0.497603 |
| breast cancer survivors | 0.539985 |
| cancer survivors | 0.554969 |
| radiation therapy | 0.80026 |
| Pain Symptom Manage | 0.426561 |
| cancer fatigue | 0.565306 |
| fatigue levels | 0.472762 |
| Healthy fatigue | 0.483034 |
|
| et al. | 0.481346 |
| fatigue scores | 0.45955 |
| study | 0.418279 |
| Oncol Nurs Forum | 0.493357 |
| Brief Fatigue Inventory | 0.449476 |
| persistent fatigue | 0.499021 |
| fatigue trajectory | 0.465086 |
| acute fatigue | 0.483368 |
| morning fatigue | 0.469862 |
| PUBMED Abstract | 0.401763 |
| label chronic fatigue | 0.506385 |
| reduced fatigue | 0.424645 |
| fatigue management focus | 0.514449 |
| Mental fatigue | 0.462612 |
| Abstract | 0.416565 |
| Clin Oncol | 0.445675 |
| breast cancer | 0.789754 |
| fatigue management. | 0.459872 |
| postoperative fatigue | 0.468487 |
| severe fatigue category | 0.447818 |
| Lee Fatigue Scale | 0.483435 |
| chronic fatigue syndrome | 0.508959 |
| cancer | 0.840288 |
| chronic cancer-related fatigue | 0.523182 |
|
CLICK HERE |
| 1509 |
National Cancer Institute |
Html |
en |
Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors. |
| actuarial survival rate | 0.630338 |
| significantly higher incidence | 0.497662 |
| survival rates | 0.647886 |
| excellent survival rates | 0.613575 |
| ovarian cystic neoplasms | 0.524669 |
| large series | 0.505974 |
| advanced-stage tumors | 0.534809 |
| survival rate | 0.991192 |
| serous tumors | 0.508069 |
| aggressive cytoreductive surgery | 0.508958 |
| intraperitoneal disease | 0.508061 |
| gross residual tumor | 0.624183 |
| DNA ploidy | 0.473971 |
| presumed localized tumors | 0.627355 |
| primary serous tumor | 0.543013 |
| patients | 0.874529 |
| gross residual disease. | 0.554008 |
| small bowel obstruction | 0.517717 |
| 20-year survival rates | 0.623524 |
| total abdominal hysterectomy | 0.500134 |
| malignant potential tumors | 0.654434 |
| epithelial ovarian cancers | 0.560469 |
| positive lymph nodes | 0.513754 |
| secondary cytoreductive procedure | 0.496028 |
| malignant invasive carcinomas | 0.598953 |
|
| Oncology Group study | 0.492475 |
| borderline ovarian tumors | 0.602765 |
| early-stage disease | 0.53696 |
| borderline tumors | 0.543947 |
| 7-year survival rate | 0.610698 |
| aneuploid tumors | 0.485651 |
| low malignant potential | 0.549837 |
| gross residual disease | 0.749508 |
| tumor recurrence | 0.473805 |
| so-called invasive implants | 0.548607 |
| low malignant potential. | 0.544407 |
| invasive tumors | 0.531513 |
| negative lymph nodes | 0.509204 |
| radiation therapy alters | 0.492888 |
| borderline tumor | 0.475678 |
| d’Obstetrique Annual Report | 0.515222 |
| tumor reductive surgery | 0.541448 |
| aneuploid invasive implants | 0.511492 |
| invasive implants | 0.72297 |
| life table analysis | 0.517429 |
| tumors | 0.678345 |
| completely resected tumor | 0.568634 |
| residual tumor | 0.843362 |
| large prospective study. | 0.509685 |
|
CLICK HERE |
| 1514 |
National Cancer Institute |
Html |
en |
Colon Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of colon cancer. |
| cancer spreads | 0.373962 |
| malignant tumor cells | 0.372393 |
| body | 0.414717 |
| PDQ cancer information | 0.41292 |
| clinical trial search | 0.41396 |
| stage iii colon | 0.398081 |
| diagnose colon cancer | 0.447265 |
| new blood vessels | 0.38464 |
| clinical trials | 0.682285 |
| nearby lymph nodes | 0.477802 |
| cancer information summary | 0.394223 |
| clinical trial | 0.458525 |
| colorectal cancer | 0.398281 |
| stage ii colon | 0.398385 |
| patients | 0.369754 |
| Local excision | 0.379135 |
| vascular endothelial growth | 0.370513 |
| NCI PDQ cancer | 0.376139 |
| colon cancer cells | 0.445391 |
| radiation therapy | 0.40615 |
| treatment | 0.500834 |
| nonpolyposis colorectal cancer | 0.376908 |
| nearby organs | 0.390945 |
| NCI-supported cancer | 0.38279 |
|
| cancer cells | 0.60536 |
| Cancer Information Service | 0.370496 |
| muscle layer | 0.393193 |
| specific cancer cells | 0.377629 |
| endothelial growth factor | 0.368878 |
| treatment clinical trials | 0.38265 |
| National Cancer Institute | 0.404109 |
| outermost layer | 0.398574 |
| Stage IV colon | 0.386981 |
| new treatment | 0.380079 |
| colon cancer | 0.660263 |
| rectal cancer | 0.382708 |
| metastatic colon cancer | 0.431124 |
| Colon Cancer Treatment | 0.434041 |
| blood | 0.38506 |
| cancer clinical trials | 0.433784 |
| stage | 0.431679 |
| sigmoid colon | 0.383033 |
| cancer information summaries | 0.368601 |
| colon | 0.728312 |
| comprehensive cancer information | 0.368619 |
| cancer | 0.920056 |
| colon wall | 0.603525 |
| Recurrent colon cancer | 0.449006 |
|
CLICK HERE |
| 1571 |
National Cancer Institute |
Html |
en |
Oropharyngeal Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of oropharyngeal cancer. |
| clinical trial | 0.317401 |
| treatment | 0.389236 |
| lymph node | 0.268655 |
| radiation therapy | 0.666089 |
|
| cancer | 0.907557 |
| clinical trials | 0.51831 |
| cancer cells | 0.317956 |
|
CLICK HERE |
| 1575 |
National Cancer Institute |
Html |
en |
Primary CNS Lymphoma Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of primary CNS lymphoma. |
| treatment | 0.59441 |
| malignant tumor cells | 0.410902 |
| cancer treatment | 0.387562 |
| magnetic resonance imaging | 0.302981 |
| AIDS-Related Lymphoma Treatment | 0.38242 |
| cancer cells | 0.552497 |
| diagnose primary CNS | 0.376869 |
| cancer spreads | 0.314799 |
| body | 0.390696 |
| chemotherapy | 0.325347 |
| Cancer Information Service | 0.293659 |
| PDQ cancer information | 0.395799 |
| treatment clinical trials | 0.330856 |
| National Cancer Institute | 0.418327 |
| clinical trials | 0.79992 |
| spinal cord | 0.477649 |
| normal cells | 0.306785 |
| CNS lymphoma spreads | 0.36676 |
| cancer information summary | 0.355271 |
| high-dose chemotherapy | 0.312805 |
| clinical trial | 0.527292 |
| lymph vessels | 0.292112 |
| new treatment | 0.386702 |
|
| stem cell transplant | 0.3294 |
| detailed pictures | 0.29332 |
| patients | 0.363752 |
| external radiation therapy | 0.330212 |
| blood | 0.30715 |
| nuclear magnetic resonance | 0.30502 |
| bone marrow | 0.337702 |
| PDQ summary | 0.321843 |
| brain radiation therapy | 0.396953 |
| treatment clinical trial | 0.299448 |
| lymphoma cells | 0.314276 |
| NCI PDQ cancer | 0.30844 |
| tests | 0.319628 |
| primary intraocular lymphoma | 0.315344 |
| cancer clinical trials | 0.309551 |
| metastatic CNS lymphoma | 0.367075 |
| radiation therapy | 0.605061 |
| treatment options | 0.328184 |
| Treatment Editorial Board | 0.31416 |
| primary cns | 0.98741 |
| cancer | 0.865897 |
| standard treatment | 0.301659 |
| positron emission tomography | 0.306717 |
|
CLICK HERE |
| 1648 |
National Cancer Institute |
Html |
en |
Acupuncture (PDQ®)–Patient Version |
Expert-reviewed information summary about acupuncture as a treatment for people with cancer or cancer-related disorders. |
| sham acupuncture | 0.790117 |
| cancer treatment | 0.64041 |
| real acupuncture | 0.712021 |
| States practice acupuncture | 0.64678 |
| acupuncture practitioner | 0.636806 |
| PDQ cancer information | 0.592449 |
| Microwave acupuncture | 0.620692 |
| clinical trials | 0.757112 |
| acupuncture treatment | 0.66786 |
| cancer information summary | 0.574467 |
| clinical trial | 0.596368 |
| patients | 0.696397 |
| cancer patients | 0.661009 |
| breast cancer survivors | 0.616253 |
| standard care | 0.619139 |
| sham acupuncture group | 0.64456 |
| acupuncture clinical observation | 0.630268 |
| acupuncture needle | 0.654731 |
| acupuncture needles | 0.653493 |
| hot flashes | 0.628474 |
| radiation therapy | 0.576978 |
| real acupuncture works | 0.632379 |
| randomized clinical trials | 0.584867 |
| cancer information | 0.604795 |
| additional acupuncture | 0.614493 |
|
| Acupuncture point injection | 0.633801 |
| United States | 0.574545 |
| Cancer Information Service | 0.583177 |
| Laser acupuncture | 0.622096 |
| acupuncture points | 0.640397 |
| acupuncture point | 0.639768 |
| Auricular acupuncture | 0.62262 |
| studies | 0.661016 |
| National Cancer Institute | 0.633121 |
| sham acupuncture groups | 0.64373 |
| alternative medicine | 0.568566 |
| acupuncture improved xerostomia | 0.627172 |
| pain | 0.585716 |
| therapy | 0.586612 |
| acupuncture practice | 0.611162 |
| acupuncture techniques | 0.624193 |
| breast cancer | 0.617659 |
| traditional Chinese medicine | 0.580302 |
| acupuncture methods | 0.624551 |
| acupuncture method | 0.623018 |
| true acupuncture | 0.617235 |
| acupuncture | 0.900286 |
| Trigger point acupuncture | 0.633788 |
| specific acupuncture point | 0.629179 |
|
CLICK HERE |
| 1776 |
National Cancer Institute |
Html |
es |
La nutrición en el tratamiento del cáncer (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca de las causas y el tratamiento de los problemas de nutrición que se presentan en pacientes de cáncer. |
| Oncology Nutrition Dietetic | 0.794305 |
| Nutrition risk screening | 0.380015 |
| Perioperative nutrition support | 0.325434 |
| August DA | 0.321534 |
| Bergerson S | 0.42802 |
| medical oncology patients | 0.319644 |
| American Cancer Society | 0.354235 |
| Malnutrition Screening Tool | 0.336109 |
| American Society | 0.333545 |
| Adult Oncology Patient | 0.321746 |
| Cancer Res | 0.323371 |
| nutrition interventions across | 0.325357 |
| Leser M | 0.456946 |
| cancer patients | 0.534602 |
| Hematol Oncol Clin | 0.319076 |
| Enteral Nutrition | 0.453095 |
| oncology patient | 0.475881 |
| Parenter Enteral Nutr | 0.377081 |
| Nutrition Risk Screening-2002 | 0.325017 |
| nutrition therapy | 0.376862 |
| pacientes quizás | 0.322377 |
| Nutrition Dietetic Practice | 0.754692 |
| Medical nutrition therapy | 0.368433 |
| Subjective Global Assessment | 0.322733 |
| terapia nutricional | 0.340919 |
|
| surgical oncology patients | 0.340122 |
| clinical practice | 0.555659 |
| Radiation Oncology Nursing | 0.334481 |
| Care Cancer | 0.324544 |
| Academy’s Oncology Nutrition | 0.372909 |
| Dietetic Practice Group | 0.607536 |
| nutrition risk | 0.383416 |
| Modern Nutrition | 0.321534 |
| Oncology Nutrition Evidence | 0.344953 |
| Oncology Nursing Practice | 0.345995 |
| Top Clin Nutr | 0.321751 |
| Nutrition assessment | 0.344971 |
| nutrition impact symptoms | 0.345866 |
| Clin Nutr | 0.326461 |
| cancer cachexia | 0.388006 |
| Clinical Nutrition | 0.351661 |
| Clin Oncol | 0.323666 |
| nutrition support therapy | 0.32555 |
| Ledesma N | 0.427589 |
| Oncology Nursing Society | 0.390831 |
| Oncology Nutrition | 0.930511 |
| Oncology Nursing | 0.416659 |
| Patient-Generated Subjective Global | 0.319243 |
| Nutrition management | 0.340043 |
|
CLICK HERE |
| 1785 |
National Cancer Institute |
Html |
es |
Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación. |
| adjustment disorders | 0.371593 |
| psychologic distress screening | 0.379318 |
| brief screening | 0.406438 |
| NCCN's rapid screening | 0.36439 |
| Sin sufrimiento | 0.48459 |
| psychological distress | 0.370051 |
| distress thermometer | 0.532993 |
| Cancer Therapy | 0.378399 |
| with early | 0.358435 |
| National Comprehensive Cancer | 0.924903 |
| Cancer Network Distress | 0.416524 |
| self-rating depression scale | 0.589802 |
| major depression | 0.374428 |
| Jacobsen PB | 0.439029 |
| Cancer Center | 0.427766 |
| Manual Diagnóstico | 0.368702 |
| mood states | 0.377645 |
| Natl Cancer Inst | 0.393821 |
| trastornos mentales | 0.667498 |
| Comprehensive Cancer Network | 0.926182 |
| rapid screening | 0.44139 |
| with cancer | 0.88971 |
| psychologic distress | 0.551057 |
| Pain Symptom Manage | 0.380417 |
| Hegel MT | 0.363843 |
|
| Akechi T | 0.365541 |
| Zung Self-Rating Depression | 0.495839 |
| Cancer anxiety | 0.395937 |
| American Psychiatric Association | 0.655757 |
| hospital anxiety | 0.404002 |
| Memorial Sloan-Kettering Cancer | 0.384863 |
| with newly | 0.361717 |
| mammography among screening | 0.361533 |
| Oxford University | 0.368144 |
| Johns Hopkins Cancer | 0.382693 |
| Patient With Cancer | 0.418527 |
| New York | 0.365014 |
| Community Cancer Care | 0.386652 |
| bone marrow transplant | 0.361659 |
| Brief Symptom Inventory | 0.536917 |
| newly diagnosed breast | 0.450645 |
| Clin Oncol | 0.474801 |
| Collins ED | 0.360494 |
| Kornblith AB | 0.373648 |
| depression scale | 0.783205 |
| Trask PC | 0.363008 |
| newly diagnosed | 0.546482 |
| sufrimiento extremo | 0.559882 |
| Holland JC | 0.426093 |
|
CLICK HERE |
| 2031 |
National Cancer Institute |
Html |
es |
Tratamiento de la enfermedad trofoblástica de la gestación (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de la enfermedad trofoblástica de la gestación. |
| Glándula tiroidea hiperactiva | 0.562015 |
| maligna.Molas invasoras | 0.545444 |
| siguientes procedimientos | 0.560552 |
| estadio iv | 0.537226 |
| siguientes aspectos | 0.546924 |
| tumores trofoblásticos epitelioides | 0.805684 |
| molas invasoras | 0.909175 |
| vÃa oral | 0.5248 |
| rayos x | 0.529833 |
| enlace drugs approved | 0.541637 |
| gonadotropina coriónica huma | 0.544512 |
| Gestational Trophoblastic Disease | 0.542392 |
| National Cancer Institute | 0.526399 |
| ecografÃa transvaginal | 0.535921 |
| siguientes riesgos | 0.522487 |
| Instituto Nacional | 0.591908 |
| áreas anormales.ampliar examen | 0.55209 |
|
| cuerpo elabora hormona | 0.593063 |
| PDQ Tratamiento | 0.555876 |
| gestación causa efectos | 0.735263 |
| molares.ampliar dilatación | 0.527024 |
| partes distantes | 0.78863 |
| siguientes factores | 0.551671 |
| Physician Data Query | 0.592879 |
| estadio i | 0.537379 |
| último panel | 0.524777 |
| estadio iii | 0.537123 |
| término enfermedad | 0.57453 |
| siguientes operaciones | 0.536826 |
| histerectomÃa laparoscópica total.Ampliar | 0.550873 |
| siguientes enlaces | 0.525533 |
| histerectomÃa abdominal | 0.531238 |
| siguientes pruebas | 0.60278 |
|
CLICK HERE |
| 15983 |
National Cancer Institute |
Video |
en |
Human Papillomavirus (HPV) | Did You Know? |
Highlighting key topics in cancer surveillance, this video from the National Cancer Institute (NCI) looks at Human Papillomavirus trends in the United States.
Here is NCI's information on HPV:
http://www.cancer.gov/hpv-factsheet
Find more cancer statistics from NCI's Surveillance, Epidemiology, and End Results (SEER) Program:
http://www.seer.cancer.gov |
| cancer statistics | 0.370109 |
| 01 | 0.310231 |
| HPV Infection | 0.628855 |
| Clark Hansen | 0.355498 |
| Normal Pap | 0.357467 |
| HPV Treatment | 0.637769 |
| Epidemiology | 0.310948 |
| Beautiful Ashes Testimonial | 0.401047 |
| JoAnna Wawrzycki_Rutland Regional | 0.401453 |
| MD | 0.32002 |
| Dr. Jennifer Lang | 0.413448 |
| American Sexual Health | 0.40243 |
| Sherry Livingston | 0.355463 |
| Tricia | 0.323082 |
| Abnormal PAPs | 0.364897 |
| Program | 0.311153 |
| hpv symptoms | 0.677726 |
| Duration | 0.809923 |
| HPV Vaccine | 0.648709 |
| autoplay | 0.333379 |
| key topics | 0.369348 |
| cancer surveillance | 0.370487 |
| NCI | 0.341035 |
| Introduction | 0.310463 |
|
| Warts Treatment | 0.357942 |
| Human Papilloma Virus | 0.411812 |
| Regional Medical Center | 0.493632 |
| United States | 0.36887 |
| Sym Tv | 0.364893 |
| Natural History | 0.359855 |
| Lauren Brim | 0.367672 |
| video | 0.322853 |
| Anderson Cancer Center | 0.410044 |
| DocMikeEvans | 0.310884 |
| National Cancer Institute | 0.4288 |
| views | 0.496544 |
| Cured Her HPV | 0.595526 |
| Cure HPV Naturally | 0.688172 |
| http://www.seer.cancer.gov | 0.311956 |
| Human Papillomavirus trends | 0.438626 |
| HPV Myths | 0.614283 |
| Rutland Regional Medical | 0.400648 |
| CBS News | 0.355791 |
| hpv | 0.931128 |
| common HPV symptoms | 0.674318 |
| dramatichealth | 0.310434 |
| Terri Bork | 0.36584 |
| Natural Treatments | 0.357354 |
|
CLICK HERE |